4//SEC Filing
Aviragen Therapeutics, Inc. 4
Accession 0001437749-16-037322
$VXRTCIK 0000072444operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:21 PM ET
Size
5.3 KB
Accession
0001437749-16-037322
Insider Transaction Report
Form 4
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Transactions
- Award
Stock Option (Right to Buy)
2016-08-11$1.30/sh+380,000$494,000→ 1,478,929 totalExercise: $1.30From: 2017-08-11Exp: 2026-08-11→ Common Stock (380,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal annual installments beginning on the first anniversary and thereafter on the second and third anniversary ratably.
Documents
Issuer
Aviragen Therapeutics, Inc.
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:21 PM ET
- Size
- 5.3 KB